Cargando…
The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review
Hypoglycemia is a major barrier impeding glycemic control in persons with type 2 diabetes mellitus and creates a substantial burden on the healthcare system. Certain populations that require special attention, such as older adults and individuals with renal impairment, a longer duration of diabetes...
Autores principales: | Cheng, Alice Y. Y., Wong, Jencia, Freemantle, Nick, Acharya, Shamasunder H., Ekinci, Elif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547921/ https://www.ncbi.nlm.nih.gov/pubmed/32975710 http://dx.doi.org/10.1007/s13300-020-00925-8 |
Ejemplares similares
-
Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review
por: Ghosh, Sujoy, et al.
Publicado: (2023) -
Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)
por: Black, Jason E., et al.
Publicado: (2023) -
Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
por: Fadini, Gian Paolo, et al.
Publicado: (2019) -
The metabolic and mitogenic properties of basal insulin analogues
por: Tennagels, Norbert, et al.
Publicado: (2013) -
Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)